Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8553810 | Toxicology in Vitro | 2018 | 9 Pages |
Abstract
Bisnaphthalimides are DNA intercalators of potential use as chemotherapeutics but for which the range of mechanism of action is only gradually being elucidated. Using human promyelocytic HL-60 cells, we extend characterization of the cytotoxicity of bisnaphthalimidopropylspermidine (BNIPSpd) and examine the relationship with caspase-activity. Within 4â¯h exposure, BNIPSpd (1-10â¯Î¼M) induced significant DNA strand breakage. Evidence of apoptosis was progressive through the experimental period. Within 6â¯h, BNIPSpd increased the proportion of cells exhibiting plasma membrane phosphatidylserine exposure. Within 12â¯h, active caspase expression increased and was sustained with 5 and 10â¯Î¼M BNIPSpd. Flow cytometric analysis revealed caspase activity in cells with and without damaged membranes. By 24â¯h, 5 and 10â¯Î¼M BNIPSpd increased hypodiploid DNA content and internucleosomal DNA fragmentation (DNA ladders) typical of the later stages of apoptosis. 1â¯Î¼M BNIPSpd exposure also increased hypodiploid DNA content by 48â¯h. Polyamine levels decreased by 24â¯h BNIPSpd exposure. The pan-caspase inhibitor, z-VAD-fmk, significantly decreased DNA degradation (hypodiploid DNA and DNA ladders) and cytotoxicity. Despite this, cell growth and viability remained significantly impaired. We propose that BNIPSpd cytotoxicity arises through DNA damage and not polyamine depletion and that cytotoxicity is dominated by but not dependent upon caspase driven apoptosis.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Charles S. Bestwick, Lesley Milne, Anne-Marie Dance, Gaela Cochennec, Gillian Cruickshank, Eflamm Allain, Lynda Constable, Susan J. Duthie, Paul Kong Thoo Lin,